cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/ccdc.csd.cc29gw0p
title: CCDC 2129452: Experimental Crystal Structure Determination

description: Related Article: Maruthupandi Mannarsamy, Muneshwar Nandeshwar, Sabari Veerapathiran, Suman Mandal, Dinesh Harijan, Kalaivanan Subramaniyam, Gopendra Muduli, Ganesan Prabusankar|2022|New J.Chem.|46|10256|doi:10.1039/D2NJ01151D
DOI: 10.5517/ccdc.csd.cc2b7862
title: CCDC 2151933: Experimental Crystal Structure Determination

description: Related Article: Yasemin Tümer, Nuran Asmafiliz, Zeynel Kılıç, Tuncer Hökelek|2022|New J.Chem.|46|10368|doi:10.1039/D2NJ00846G
DOI: 10.5517/ccdc.csd.cc2b7873
title: CCDC 2151934: Experimental Crystal Structure Determination

description: Related Article: Yasemin Tümer, Nuran Asmafiliz, Zeynel Kılıç, Tuncer Hökelek|2022|New J.Chem.|46|10368|doi:10.1039/D2NJ00846G
DOI: 10.5517/ccdc.csd.cc2b7884
title: CCDC 2151935: Experimental Crystal Structure Determination

description: Related Article: Yasemin Tümer, Nuran Asmafiliz, Zeynel Kılıç, Tuncer Hökelek|2022|New J.Chem.|46|10368|doi:10.1039/D2NJ00846G
DOI: 10.5517/ccdc.csd.cc29gcrx
title: CCDC 2128979: Experimental Crystal Structure Determination

description: Related Article: Hongmei Qin, Qimei Xie, Long He|2022|New J.Chem.|46|9985|doi:10.1039/D2NJ00936F
DOI: 10.5517/ccdc.csd.cc29csfx
title: CCDC 2126489: Experimental Crystal Structure Determination

description: Related Article: Sivakalai Mayakrishnan, Devarajan Kathirvelan, Yuvaraj Arun, Krishnan Saranraj, Chandrasekaran Balachandran, Shin Aoki, Pannerselvam Yuvaraj, Narayanan Uma Maheswarai|2022|New J.Chem.|46|10089|doi:10.1039/D1NJ05839H
DOI: 10.5517/ccdc.csd.cc29d877
title: CCDC 2126948: Experimental Crystal Structure Determination

description: Related Article: Sivakalai Mayakrishnan, Devarajan Kathirvelan, Yuvaraj Arun, Krishnan Saranraj, Chandrasekaran Balachandran, Shin Aoki, Pannerselvam Yuvaraj, Narayanan Uma Maheswarai|2022|New J.Chem.|46|10089|doi:10.1039/D1NJ05839H
DOI: 10.5517/ccdc.csd.cc2b5ddb
title: CCDC 2150141: Experimental Crystal Structure Determination

description: Related Article: M.J.M. Zapata, W.X.C. Oliveira, C.B. Pinheiro|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|332|doi:10.1107/S205322962200451X
DOI: 10.5517/ccdc.csd.cc2b5dfc
title: CCDC 2150142: Experimental Crystal Structure Determination

description: Related Article: M.J.M. Zapata, W.X.C. Oliveira, C.B. Pinheiro|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|332|doi:10.1107/S205322962200451X
DOI: 10.5517/ccdc.csd.cc2b5dgd
title: CCDC 2150143: Experimental Crystal Structure Determination

description: Related Article: M.J.M. Zapata, W.X.C. Oliveira, C.B. Pinheiro|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|332|doi:10.1107/S205322962200451X
DOI: 10.5517/ccdc.csd.cc2b5dhf
title: CCDC 2150144: Experimental Crystal Structure Determination

description: Related Article: M.J.M. Zapata, W.X.C. Oliveira, C.B. Pinheiro|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|332|doi:10.1107/S205322962200451X
DOI: 10.5517/ccdc.csd.cc2b5djg
title: CCDC 2150145: Experimental Crystal Structure Determination

description: Related Article: M.J.M. Zapata, W.X.C. Oliveira, C.B. Pinheiro|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|332|doi:10.1107/S205322962200451X
DOI: 10.5517/ccdc.csd.cc2b5dkh
title: CCDC 2150146: Experimental Crystal Structure Determination

description: Related Article: M.J.M. Zapata, W.X.C. Oliveira, C.B. Pinheiro|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|332|doi:10.1107/S205322962200451X
DOI: 10.5517/ccdc.csd.cc2btj3t
title: CCDC 2169476: Experimental Crystal Structure Determination

description: Related Article: M.J.M. Zapata, W.X.C. Oliveira, C.B. Pinheiro|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|332|doi:10.1107/S205322962200451X
DOI: 10.5517/ccdc.csd.cc2bqmb1
title: CCDC 2166693: Experimental Crystal Structure Determination

description: Related Article: S.A. Ranaweera, D. Bruno, W.P. Henry, M.G. White|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|338|doi:10.1107/S2053229622004582
DOI: 10.5517/ccdc.csd.cc28z35k
title: CCDC 2114298: Experimental Crystal Structure Determination

description: Related Article: Lu Liu, Yue-Ming Yu, Yu Yu, Fan-Zhi Bu, Zhi-Yong Wu, Cui-Wei Yan, Yan-Tuan Li|2022|New J.Chem.|46|10357|doi:10.1039/D2NJ01509A
DOI: 10.5517/ccdc.csd.cc2btw46
title: CCDC 2169818: Experimental Crystal Structure Determination

description: Related Article: S. van Terwingen, B. Ebel, R. Wang, U. Englert|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|324|doi:10.1107/S2053229622004648
DOI: 10.5517/ccdc.csd.cc2btw57
title: CCDC 2169819: Experimental Crystal Structure Determination

description: Related Article: S. van Terwingen, B. Ebel, R. Wang, U. Englert|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|324|doi:10.1107/S2053229622004648
DOI: 10.5517/ccdc.csd.cc2btw68
title: CCDC 2169820: Experimental Crystal Structure Determination

description: Related Article: S. van Terwingen, B. Ebel, R. Wang, U. Englert|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|324|doi:10.1107/S2053229622004648
DOI: 10.5517/ccdc.csd.cc2b5871
title: CCDC 2150012: Experimental Crystal Structure Determination

description: Related Article: S.M. Jo, T.H. Noh|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|360|doi:10.1107/S2053229622004818
DOI: 10.5517/ccdc.csd.cc2b5882
title: CCDC 2150013: Experimental Crystal Structure Determination

description: Related Article: S.M. Jo, T.H. Noh|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|360|doi:10.1107/S2053229622004818
DOI: 10.5517/ccdc.csd.cc2bw03c
title: CCDC 2170902: Experimental Crystal Structure Determination

description: Related Article: Denis S. Koltun, Sergey M. Ivanov|2022|J.Mol.Struct.|1264|133321|doi:10.1016/j.molstruc.2022.133321
DOI: 10.5517/ccdc.csd.cc28s49j
title: CCDC 2108567: Experimental Crystal Structure Determination

description: Related Article: M. Schutte-Smith, H.G. Visser|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|351|doi:10.1107/S205322962200465X
DOI: 10.5517/ccdc.csd.cc28s4bk
title: CCDC 2108568: Experimental Crystal Structure Determination

description: Related Article: M. Schutte-Smith, H.G. Visser|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|351|doi:10.1107/S205322962200465X
DOI: 10.5517/ccdc.csd.cc2bdrvc
title: CCDC 2157223: Experimental Crystal Structure Determination

description: Related Article: H. Kaspiaruk, L. Chęcińska|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|343|doi:10.1107/S2053229622004909
DOI: 10.5517/ccdc.csd.cc2bdrwd
title: CCDC 2157224: Experimental Crystal Structure Determination

description: Related Article: H. Kaspiaruk, L. Chęcińska|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|343|doi:10.1107/S2053229622004909
DOI: 10.5517/ccdc.csd.cc2bdrxf
title: CCDC 2157225: Experimental Crystal Structure Determination

description: Related Article: H. Kaspiaruk, L. Chęcińska|2022|Acta Crystallogr.,Sect.C:Cryst.Struct.Chem.|78|343|doi:10.1107/S2053229622004909
DOI: 10.6084/m9.figshare.19928713
title: Phakic intraocular lenses for myopia and astigmatism: a prospective review

description: ABSTRACT Implantation of phakic intraocular lenses for refractive purpose is a safe and efficient elective surgical alternative. This option should be considered to electively treat ametropia when laser corneal refractive surgery has higher risk of complications, either due to corneal characteristics or the magnitude of ametropia. This article provides a prospective review of the phakic lenses available in the Brazilian market in 2020 and their characteristics.
DOI: 10.6084/m9.figshare.19928713.v1
title: Phakic intraocular lenses for myopia and astigmatism: a prospective review

description: ABSTRACT Implantation of phakic intraocular lenses for refractive purpose is a safe and efficient elective surgical alternative. This option should be considered to electively treat ametropia when laser corneal refractive surgery has higher risk of complications, either due to corneal characteristics or the magnitude of ametropia. This article provides a prospective review of the phakic lenses available in the Brazilian market in 2020 and their characteristics.
DOI: 10.6084/m9.figshare.19928716
title: Iris cyst and atypical complications

description: ABSTRACT The authors report the case of a male adult presenting significant ocular complications and irreversible visual impairment, resulting from the long-term progression and late diagnosis of an iris cyst in the right eye, probably secondary to trauma. The patient was admitted to Hospital Universitário Antonio Pedro with a total corneal opacity that blocked direct visualization of the anterior chamber. Ultrasound biomicroscopy was crucial for the anatomic study, and the patient was submitted to enucleation for aesthetic improvement and clarifying diagnosis. We concluded athalamia and deformation of the anterior segment, due to expansion of the cyst, led to gradual elevation of the intraocular pressure and damage of the optic nerve, resulting in visual loss.
DOI: 10.6084/m9.figshare.19928716.v1
title: Iris cyst and atypical complications

description: ABSTRACT The authors report the case of a male adult presenting significant ocular complications and irreversible visual impairment, resulting from the long-term progression and late diagnosis of an iris cyst in the right eye, probably secondary to trauma. The patient was admitted to Hospital Universitário Antonio Pedro with a total corneal opacity that blocked direct visualization of the anterior chamber. Ultrasound biomicroscopy was crucial for the anatomic study, and the patient was submitted to enucleation for aesthetic improvement and clarifying diagnosis. We concluded athalamia and deformation of the anterior segment, due to expansion of the cyst, led to gradual elevation of the intraocular pressure and damage of the optic nerve, resulting in visual loss.
DOI: 10.6084/m9.figshare.19928719.v1
title: Preventing glaucoma progression using the trabecular micro-bypass implant iStent inject®. A cost-effectiveness analysis

description: ABSTRACT Objective To assess the economic impact of reducing glaucoma progression by using the trabecular micro-bypass implant, iStent inject®, in the Reference Centers for glaucoma treatment within the Brazilian Public Unified Health System (SUS). Methods In a cost-effectiveness analysis, a Markov model was developed, and the costs were obtained from the SUS perspective (medical direct costs). Effectiveness was measured in progression-free life-years. The time horizon was the mean life expectancy of the Brazilian population. The model parameters were obtained through a review and a critical analysis of the literature. The base case comprised a hypothetical cohort of patients with open-angle glaucoma, using anti-glaucoma eye drops and followed up at Reference Centers of SUS. We tested whether the incorporation of iStent inject® as an alternative second-line therapy would be cost-effective. The outcome measure was the incremental cost-effectiveness ratio (R$/progression-free life-years). We tested the robustness of the model by univariate and probabilistic sensitivity analyses. Results The use of iStent inject® led to decreased progression rate of glaucoma, evidenced by the amount of progression-free life-years obtained with each treatment strategy (7.82 progression-free life-years with iStent inject® versus 6.33 progression-free life-years with medical treatment), thereby improving glaucoma control. There was also a reduction in future costs associated with eye drops, filtering surgeries, and treatment complications. Incremental cost-effectiveness ratio ranged from R$ 6,429.30 to R$ 7,550.97/progression-free life-years. The model proved to be robust in the sensitivity analyses. Conclusion This analysis showed that iStent inject®, when used after the failure of the first-line therapy, is able to reduce the rate of glaucoma progression at an acceptable cost.
DOI: 10.6084/m9.figshare.19928719
title: Preventing glaucoma progression using the trabecular micro-bypass implant iStent inject®. A cost-effectiveness analysis

description: ABSTRACT Objective To assess the economic impact of reducing glaucoma progression by using the trabecular micro-bypass implant, iStent inject®, in the Reference Centers for glaucoma treatment within the Brazilian Public Unified Health System (SUS). Methods In a cost-effectiveness analysis, a Markov model was developed, and the costs were obtained from the SUS perspective (medical direct costs). Effectiveness was measured in progression-free life-years. The time horizon was the mean life expectancy of the Brazilian population. The model parameters were obtained through a review and a critical analysis of the literature. The base case comprised a hypothetical cohort of patients with open-angle glaucoma, using anti-glaucoma eye drops and followed up at Reference Centers of SUS. We tested whether the incorporation of iStent inject® as an alternative second-line therapy would be cost-effective. The outcome measure was the incremental cost-effectiveness ratio (R$/progression-free life-years). We tested the robustness of the model by univariate and probabilistic sensitivity analyses. Results The use of iStent inject® led to decreased progression rate of glaucoma, evidenced by the amount of progression-free life-years obtained with each treatment strategy (7.82 progression-free life-years with iStent inject® versus 6.33 progression-free life-years with medical treatment), thereby improving glaucoma control. There was also a reduction in future costs associated with eye drops, filtering surgeries, and treatment complications. Incremental cost-effectiveness ratio ranged from R$ 6,429.30 to R$ 7,550.97/progression-free life-years. The model proved to be robust in the sensitivity analyses. Conclusion This analysis showed that iStent inject®, when used after the failure of the first-line therapy, is able to reduce the rate of glaucoma progression at an acceptable cost.
DOI: 10.6084/m9.figshare.19928722
title: Social action to detect and solve low visual acuity in adolescents

description: ABSTRACT Objective To verify the prevalence and the main causes of low visual acuity among students, to correct refractive errors with eyewear, and to establish a relation between vision and school performance. Methods This is a cross-sectional, quantitative study of a social action carried out in a public elementary and high school in the city of Araçatuba (SP). Specialized evaluation was indicated to students who presented visual acuity ≤0.7 in one or both eyes, with or without prior optical correction, upon triage. Glasses were delivered to everyone who needed better vision. The analysis was performed based on screening record and student’s school grade, using Excel and BioEstat software. Results Out of 503 students screened, 75 (15%) presented low visual acuity. Sixty-six (88%) attended the scheduled visit and 50 (80.65%) received ready-made glasses. The mean age was 15±2 years, and there was a predominance of females (64.5%). Refractive errors were the main cause of visual impairment (90.3%) and myopia, associated or not to astigmatism, was the most prevalent condition (63%). Thirteen (21%) students had anisometropia. There was no statistically significant difference (p=0.5479) in annual average grade of students with low visual acuity and those with normal vision. Conclusion Social projects for visual triage are carried out without effort, have a low cost and high problem-solving capacity, since refractive errors are the most frequent diagnoses and easily corrected with glasses. The low visual acuity detected in students did not interfere in their school performance.
DOI: 10.6084/m9.figshare.19928722.v1
title: Social action to detect and solve low visual acuity in adolescents

description: ABSTRACT Objective To verify the prevalence and the main causes of low visual acuity among students, to correct refractive errors with eyewear, and to establish a relation between vision and school performance. Methods This is a cross-sectional, quantitative study of a social action carried out in a public elementary and high school in the city of Araçatuba (SP). Specialized evaluation was indicated to students who presented visual acuity ≤0.7 in one or both eyes, with or without prior optical correction, upon triage. Glasses were delivered to everyone who needed better vision. The analysis was performed based on screening record and student’s school grade, using Excel and BioEstat software. Results Out of 503 students screened, 75 (15%) presented low visual acuity. Sixty-six (88%) attended the scheduled visit and 50 (80.65%) received ready-made glasses. The mean age was 15±2 years, and there was a predominance of females (64.5%). Refractive errors were the main cause of visual impairment (90.3%) and myopia, associated or not to astigmatism, was the most prevalent condition (63%). Thirteen (21%) students had anisometropia. There was no statistically significant difference (p=0.5479) in annual average grade of students with low visual acuity and those with normal vision. Conclusion Social projects for visual triage are carried out without effort, have a low cost and high problem-solving capacity, since refractive errors are the most frequent diagnoses and easily corrected with glasses. The low visual acuity detected in students did not interfere in their school performance.
DOI: 10.6084/m9.figshare.19928725.v1
title: Effects of the excessive use of electronic screens on vision and emotional state

description: ABSTRACT Objective To investigate relations between electronic screen use and eye health in a representative sample of the Brazilian population. Methods Data were collected online and analyzed at a private Brazilian hospital (Provisão Hospital, Maringá, Brazil). Male and female individuals aged 12 to 35 years participated in the study. A population-based cross-sectional survey based on a questionnaire developed using the Google Forms interface was carried out. The questionnaire was answered anonymously in order to ensure the confidentiality of data and the privacy of participants. Data were collected between October 13, 2020, and January 30, 2021. Results A total of 200 questionnaires were completed. Most responders were young people aged 18 to 27 years. Daily electronic device use time reported by responders ranged from more than 5 hours (150; 75.5%) to 3 to 5 hours/day (28; 14%) or 2 to 3 hours/day (16; 8%). Only a small proportion of responders (2.5%) used these devices less than 1 hour per day. Most participants had myopia (164; 84%) and/or astigmatism (151; 75.5%), whereas keratoconus was less prevalent (34; 17%). However, 92 participants were unable to say whether they had these diseases or not. Most participants reported eye symptoms after screen use (red eyes, fatigue, dry and gritty eyes and blurred vision). Mental issues such as smartphone dependence and difficulties to communicate while using electronic devices were also addressed. Most responders reported dependence and communication problems. Conclusions Most young people in this sample had sings of eye disease, including keratoconus. Smartphone dependence and addition was also observed. Findings presented may inform future studies and help health authorities to properly guide public health strategies aimed at eye disease prevention.
DOI: 10.6084/m9.figshare.19928725
title: Effects of the excessive use of electronic screens on vision and emotional state

description: ABSTRACT Objective To investigate relations between electronic screen use and eye health in a representative sample of the Brazilian population. Methods Data were collected online and analyzed at a private Brazilian hospital (Provisão Hospital, Maringá, Brazil). Male and female individuals aged 12 to 35 years participated in the study. A population-based cross-sectional survey based on a questionnaire developed using the Google Forms interface was carried out. The questionnaire was answered anonymously in order to ensure the confidentiality of data and the privacy of participants. Data were collected between October 13, 2020, and January 30, 2021. Results A total of 200 questionnaires were completed. Most responders were young people aged 18 to 27 years. Daily electronic device use time reported by responders ranged from more than 5 hours (150; 75.5%) to 3 to 5 hours/day (28; 14%) or 2 to 3 hours/day (16; 8%). Only a small proportion of responders (2.5%) used these devices less than 1 hour per day. Most participants had myopia (164; 84%) and/or astigmatism (151; 75.5%), whereas keratoconus was less prevalent (34; 17%). However, 92 participants were unable to say whether they had these diseases or not. Most participants reported eye symptoms after screen use (red eyes, fatigue, dry and gritty eyes and blurred vision). Mental issues such as smartphone dependence and difficulties to communicate while using electronic devices were also addressed. Most responders reported dependence and communication problems. Conclusions Most young people in this sample had sings of eye disease, including keratoconus. Smartphone dependence and addition was also observed. Findings presented may inform future studies and help health authorities to properly guide public health strategies aimed at eye disease prevention.
DOI: 10.6084/m9.figshare.19928728
title: Recurrent intraocular hypertension during hemodialysis in glaucoma patient

description: ABSTRACT Acute ocular hypertension during hemodialysis is a rare event and may lead to interruption of dialytic therapy due to pain. A case of a 70-year-old male patient is reported, who presented recurrent intense unilateral ocular pain episodes during dialysis sessions for increased intraocular pressure. The patient presented with severely decreased visual acuity in the right eye due to neovascular glaucoma, which was controlled with topical hypotensive medication. One hour after initiating dialysis, he presented an excruciating pain on the right eye, which required interruption of treatment several times. Pain relief was possible only with intravenous opioids, or approximately 6 hours after dialysis. Intraocular injection of antiangiogenic drugs and per oris acetazolamide, as well as other traditional treatments for acute episodes of intraocular hypertension, such as topical antihypertensive agents and hyperosmotic medications, were not sufficient to control pain. The problem was solved with transscleral diode laser cyclophotocoagulation, which reduced baseline intraocular pressure and controlled pain, enabling complete hemodialysis sessions. The pathophysiological aspects and therapeutic options of this unusual condition are discussed.
DOI: 10.6084/m9.figshare.19928728.v1
title: Recurrent intraocular hypertension during hemodialysis in glaucoma patient

description: ABSTRACT Acute ocular hypertension during hemodialysis is a rare event and may lead to interruption of dialytic therapy due to pain. A case of a 70-year-old male patient is reported, who presented recurrent intense unilateral ocular pain episodes during dialysis sessions for increased intraocular pressure. The patient presented with severely decreased visual acuity in the right eye due to neovascular glaucoma, which was controlled with topical hypotensive medication. One hour after initiating dialysis, he presented an excruciating pain on the right eye, which required interruption of treatment several times. Pain relief was possible only with intravenous opioids, or approximately 6 hours after dialysis. Intraocular injection of antiangiogenic drugs and per oris acetazolamide, as well as other traditional treatments for acute episodes of intraocular hypertension, such as topical antihypertensive agents and hyperosmotic medications, were not sufficient to control pain. The problem was solved with transscleral diode laser cyclophotocoagulation, which reduced baseline intraocular pressure and controlled pain, enabling complete hemodialysis sessions. The pathophysiological aspects and therapeutic options of this unusual condition are discussed.